CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Phase II Study of Topotecan and Etoposide as Second-line Treatment in Chemotherapy-refractory Small-cell Lung Cancer

Chul Kim, Joo Hyuk Sohn, Joo Hang Kim, Se Kyu Kim, Young Sam Kim, Joon Chang, Jae Yong Cho

Cancer Research and Treatment. 2002;34(5):334-338. Published online 2002 October 31 DOI: https://doi.org/10.4143/crt.2002.34.5.334

Phase II studies of topotecan in patients with non-small cell lung cancer (NSCLC) previously untreated and patients with small cell lung (SCLC) cancer refractory to etoposide

Lung Cancer. 1994;11:126

Link1 Link2

EORTC LCCG Phase II study of topotecan in combination with cisplatin as second line chemotherapy of sensitive and refractory small cell lung cancer (SCLC)

A Ardizzoni, C Manegold, C Debruyne, R Gaafar, E Buchholz, S Dussenne, C Legrand, K King, G Giaccone

Lung Cancer. 2000;29(1):51

Link1 Link2

A phase II study testing weekly platinum derivative combination chemotherapy as second-line treatment in patients with advanced small cell lung cancer

Lung Cancer. 1995;12(3):277

Link1 Link2

Combined chemotherapy with etoposide, irinotecan plus cisplatin compared with topotecan monotherapy as the second-line treatment in sensitive relapsed small cell lung cancer: A retrospective analysis

H. Wang

Annals of Oncology. 2017;28:ii17

Link1 Link2 Link3

Randomized Phase Ii Study of Belotecan or Topotecan Chemotherapy As Second-Line Chemotherapy After Platinum-Based First-Line Chemotherapy for Small Cell Lung Cancer

S. Yoon, D.H. Lee, C. Choi, J.C. Lee, J.S. Lee, S. Kim

Annals of Oncology. 2014;25:iv515

Link1 Link2 Link3

Phase II study of carboplatin and adriamycin as second line chemotherapy in small cell lung cancer

Lung Cancer. 1994;10(5-6):423

Link1 Link2

P-576 Phase II trial of weekly topotecan in the second-line treatment of small cell lung cancer

F. Anthony Greco, Howard A. Burris, Denise Aysel Yardley, John Daniel Hainsworth

Lung Cancer. 2003;41:S237

Link1 Link2

A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer

M Joppert

Lung Cancer. 2003;39(2):215-219

Link1 Link2

Combination Chemotherapy with Irinotecan and Ifosfamide as Second-Line Treatment of Refractory or Sensitive Relapsed Small Cell Lung Cancer: A Phase II Study

Masao Ichiki, Rumi Gohara, Toru Rikimaru, Takao Kitajima, Rei Fujiki, Akiko Shimada, Hisamichi Aizawa

Chemotherapy. 2003;49(4):200-205

Link1 Link2

Topotecan (T) as second-line therapy following ifosfamide-carboplatin-etoposide (ICE) and maintenance for small cell lung cancer (SCLC)

T Ruotsalainen, K Mattson

Lung Cancer. 2000;29(1):67

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.